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We have recently described the sequence of the Zn2+-binding domain (43 amino acid residues) of a newly detected Zn 2+- 
binding protein which reversibly inactivates phosphofructokinase-I in a Zn2+-dependent manner [(1986) J. Biol. Chem. 
269, 5895-5900; (1988) Eur. J. Biochem. 177, 561-568]. Here, we describe the primary sequence of this protein based on 
a full-length cDNA. A sequence comparison reveals the identity of the Zn 2÷-binding protein with a protein called para- 
thymosin-ct. 
Zinc-binding protein; Phosphofructokinase- 1; Parathymosine-ct 
1. INTRODUCTION 
Brand and Srling [1] have reported on a protein 
with an apparent Mr of 19000, which inactivates 
phosphofructokinase-1 (PFK-1; EC 2.7.1.11) in a 
Zn2+-dependent manner. The inactivation of 
PFK-1 is reversible upon removal of  the zinc ions. 
A peptide containing the four Zn2+-binding do- 
mains of this molecule was identified and sequenc- 
ed [2]. This peptide was still able to inactivate 
PFK-1 [2]. 
Based on the partial sequence obtained, 
oligonucleotides were synthesized and used for 
screening a Agt-11 rat liver library. Positive clones 
were identified and a full-length cDNA was se- 
quenced. Based on this cDNA, the primary se- 
quence of the Zn2+-binding protein was deduced. 
A comparison of the obtained sequence with data 
in the literature led to the result that the 
Zn2+-binding protein is identical with rat 
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parathymosin-tr, a recently identified protein, 
whose function had remained more or less 
unknown up to now [3-5]. 
2. MATERIALS AND METHODS 
2.1. Materials 
The Agtll rat liver cDNA library was obtained from 
Clontech, Heidelberg, FRG. T4-polynucleotide kinase, 
T4-1igase, EcoRI, bacterial alkaline phosphatase, [7)2p]ATP 
and [oe)sS]dATP as well as Hybond N nylon membranes came 
from the Amersham-Buchler Co., Braunschweig, FRG. The 
Sequenase-2.0 kit was from United States Biochemicals Co., 
Cleveland, OH, USA. Blots were performed using 
GeneScreenPlus from NEN-Dupont, Bad Homburg, FRG, 
autoradiography with Kodak XAR5 film. 
2.2. Methods 
Oligonucleotides were synthesized on an Applied Biosystems 
381A oligonucleotide synthesizer. Following deprotection with 
conc. ammonia and desalting using Pharmacia NAP-10 col- 
umns, the oligonucleotides used were 5 '-end labelled using 
[7)2p]ATP and T4-polynucleotide kinase. Bacteriophage pla- 
ques were transferred onto Hybond N membranes according to 
[6] and hybridization with the labelled oligonucleotides was per- 
formed as in [7]. The hybridization temperatures were selected 
according to [7]: Positive plaques were picked and single 
positive plaques obtained by two additional rescreening cycles 
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Oliao H. 51-me[: 
Glu Glu Glu Glu Asn Gly Ala Glu GIu Glu Glu GIu Glu 
5'GAG GAG GAG GAG AAC GGC GCC GAG GAG GAG GAG GAG GAG 
U U 
3 'CTC CTC CTC CTC TTG CCG CGG CTC CTC CTC CTC CTC CTC 
A A 
Thr Ala GIu Asp 
ACC GCC GAG GAC 3' 
U U 
TGG CGG CTC CTG 5' 
A A 
Oliao G, 45-mer: 
Glu Asp Asp Asp Glu Gly Asp GIu Glu Asp GIu Glu Glu GIU Glu 
5'GAG GAC GAC GAC GAG GGC GAC GAG GAG GAC GAG GAG GAG GAG GAG 3' 
U 
3 'CTC CTG CTG CTG CTC CCG CTG CTC CTC CTG CTC CTC CTC CTC CTC 5' 
A 
Ol i~o B. 17-me_r; 
Ser Val Glu Ala Ala Ala 
5'AGC GUG GAG GCU GCU GC 3' 
3'TCG CAC CTC CGA CGA CG 5' 
Ol icc D. 17-mer~ 
Glu Asn Gly Ala Glu Glu 
5'GAG AAC GGC GCU GAG GA 3' 
U C 
3'CTC TTG CCG CGA CTC CT 5 r 
A G 
Fig. 1. Sequences of oligonucleotides u ed for screening and 
cross-hybridization experiments. Peptide, mRNA and 
oligonucleotide s quences are shown. Probes H, G and D were 
deduced from the 43-residue peptide, B was constructed from 
an unpublished sequence of the zinc-binding protein. 
using the same probe. Phage DNA was prepared from plate 
lysates, digested with EcoRI and separated by electrophoresis 
on 0.4°7o agarose gels. The DNA was blotted onto 
GeneScreenPlus-membranes d examined for insertion size 
and cross-hybridization with different oligonucleotides. The 
EcoR1 cut inserts were ligated into M13 mpl8 RF-DNA, which 
had been cut before with EcoRI and treated with bacterial 
alkaline phosphatase. The ligated DNA was transformed into 
competent E. coli CMK 603 cells. Sequencing of the recombi- 
nant M13 phage DNA was performed using Sequenase 2.0 ac- 
cording to the manufacturer's instructions. To prevent 
sequencing errors due to gel compressions, parallel Sequenase 
reactions were run with dGTP and dITP, respectively. The se- 
quencing strategy followed the 'primer hopping' method as 
described in [8]. 
rat liver cDNA library with oligonucleotide H 
yielded about 120 positive signals. Ten clones were 
randomly selected and survived two rescreen cycles 
with the original probe. The EcoRI-cut phage 
DNA was blotted and examined for insert size and 
tested for cross-hybridization. I serts of sizes be- 
tween 0.5 and 1.2 kb were observed, but only clone 
H3 (about 600 bp insert length) and clone H9 
(about 900 bp insert length) cross-hybridized with 
four different oligonucleotide probes. These two 
clones were selected for subcloning into M13 
mpl8. With clone H9, only five recombinant M31 
plaques could be observed in several ligation- 
transformation experiments, whereas clone H3 did 
not yield recombinant plaques at all. Of the H9 
recombinants, only one plaque provided single- 
stranded DNA which could be sequenced. This 
DNA contained, however, the complete 935 bp H9 
insert. The sequence of this DNA is depicted in 
fig.2. It is evident that H9 contains an open 
reading frame for a 11471 Da protein. The amino 
acid composition of the protein derived from the 
sequenced cDNA fits with the previously published 
data [2], and the sequence of the Zn2+-binding 
peptide reported earlier [2] can be completely 
recovered (underlined sequence in fig.2). The se- 
quenced DNA contained also 109 bp of the 
5' -untranslated and 506 bp of the 3'-untranslated 
regions including the 3'-poly-A tail. 
As the calculated molecular mass of 11471 Da 
was not in line with the molecular mass deduced 
previously from SDS-polyacrylamide gel elec- 
trophoresis (19000 Da) [1], a sample of the protein 
was analyzed by laser-time-of-flight-mass spec- 
trometry. A 'mother-peak' of 11470 Da was found 
by this method confirming the protein sequence 
deduced from the cDNA. The higher apparent 
molecular mass obtained by SDS-polyacrylamide 
gel electrophoresis results most likely from the very 
acidic character of the protein. 
3. RESULTS 
Based on the 43 residues peptide described by 
Brand et al. [2] and an additional unpublished se- 
quence, four oligonucleotides were synthetized. 
The base sequences were selected according to a 
codon usage catalogue [9] as given in fig.1. 
Screening of about 5 × 103 plaques of the Agtl 1 
4. DISCUSSION 
The recombinant full-length clone described 
here carries immediately upstream of the initiator 
codon the sequence CCC GGC ACC (positions 
107-115 in fig.2). This sequence shows a strong 
homology with the consensus sequence (GCC GCC 
ACC) for which Kozak [10] assumes a positive 
regulatory effect on the translation rate. 
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Having obtained the full-length primary struc- 
ture of the Zn2+-binding protein, we undertook a 
search in a protein sequence data library in order 
to find possible homologies with other peptides or 
proteins. To our surprise, the Zn2+-binding protein 
showed full identity with a protein of unknown 
function and properties called 'parathymosin-a'. 
The sequence of parathymosin-a had been deduc- 
ed from the sequence of a partial cDNA clone and 
a N-terminal peptide sequence [4,5]. The designa- 
tion 'parathymosin' was chosen by Haritos et al. 
[11] because it was initially found in the thymus 
together with prothymosin-a, the pro-form of the 
hormonal factor thymosin-a. However, in view of 
the fact that (in spite of a similar amino acid com- 
position) there exists only a very limited sequence 
homology between parathymosin-a and pro- 
thymosin-t~ and that much more parathymosin-d is
found in the liver than in the thymus [12,13], we 
feel that the name 'parathymosin' is misleading 
and should be replaced by the more informative 
designation '11.5 kDa Zn2+-binding protein'. On 
GAATTCCGSC CGCCGC['ACC GCGCCAAGTT CCGGCCGCGG CCACCTI I ]CG CCISTCCAGGG 
~TCCTCCGCC TCGGCCCCGG GACCCCGGCT CCCCGCCAGC CCCGGCCCCG GCACC 
60 
ATG TCG GAG AAG AGC GTG GAG GCA GCG GCC GAG CTA AGC GCC AAG 
Set  G lu  Lys  Set  Val G lu  A la  A la  A la  G lu  Leu  Set  A la  Lys  
GAC CTG AAG GAA AAG AAG GAC AAG GTG GAG GAG AAG GCT GGC CGG 
Asp Leu  Lys  G lu  Lys  Lys  Asp Lys  Val G lu  G lu  Lys  A la  G ly  Arg 
AAA GAA CGG AAG AAA GAA GTA GTG GAG GAG GAG GAG AAT GGA GCT 
Lys  G lu  Arg  Lys  Lys  G lu  Val Val G lu  G lu  G lu  G lu  Ash G ly  A la  
GAG GAG GAG GAA GAA GAA ACT GCT GAG GAT GGA GAG GAT GAT GAT 
~lu  G lu  G lu  O lu  G lu  G lu  Thr  Ala  G lu  Asp G ly  G lu  ASp Asp Asp 
GAA GGA GAC GAA GAA GAT GAG GAG GAA GAG GAG GAG GAG GAT GAA 
Glu GIy Asp Glu Glu Asp Glu Glu Glu Glu Glu Glu Glu Asp Glu 
GGC CCC GTG CGG AAG AGA ACT GCT GAA GAG GAG GAT GAA GCG GAT 
GIy Pro Val Ar~.Lys Arg Thr Ala Glu Glu Glu Asp Glu Ala Asp 
CCC AAG AGG CAG AAG ACA GAA AAC GGG GCG TCG GCT TGA 








GCCCCT GCCCGTGGGC TTGGGGATGG GAGGCCCCTC AGGFCCIGGA GGTGGGGCAG 480 
GAACACACAA ATCCAGCCCC CCTTCTCCTG GC]CCCICGT C]GGCCCTGC CCCAGAGCI-G 540 
TGACCCTTGC CCTTTGACCC AGCCTCTCAT TTCCATCTCT CCAGACACTG CICCTTCACC 60(~ 
CTCACTGCCA CAGGTCCAGC CCCCAACCCG CCTCATCCAA GCICCCCAGC CGGCCC-ICAC 660 
TTGCCCTAGC ATTCCTTGTT CTTCCCTGCC TTCCTCACCA TCGAI-CIG-I'T CCAGTCCT-I-G 720 
CGAAGCCTCT CCTTCCCCTC TGCACCCCGA GCCTCTCAGC CTGCCCITCT C~CTCCIGCC 780 
TGACCCCTGG GTCTCCCTCA GATTCCCTCC TCTCAGACAG CGCCAt3GCCG GGGI-GGGGCI 840 
GGGGTTGGGG CCAAGCCCC6 AAGCTGCCCC CTCCCCTTTT TGTATAATTT AAIAAAGAAA 900 
CGGTCSCGCT TCAAAAAAAA AAAAAAAAC8 GAATTC 936 
Fig.2. Sequence of a full-length cDNA coding for the rat liver Zn2+-binding protein and the primary sequence deduced from the cDNA. 
The underlined part of the sequence corresponds to the peptide reported previously by Brand et al. [2]. 
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the other hand, both prothymosin-ae and the 
11.5 kDa Zn2+-binding protein share a common 
property, in that both contain several clusters of 
acid amino acids separated by 1-3 neutral amino 
acids (mostly glycine). Therefore, we do consider 
the possibility that prothymosin might also be a 
Zn2+-binding protein. If this were the case, this 
property might affect its processing to the mature 
thymosin-a, the active form of the hormone. 
We observed in our study that our H9 clone had 
poor ligation/transformation activity. This fits 
data from Horecker's group who reported that 
parathymosin recombinant Bluescript KS 
M13-plasmids carrying a cDNA, containing ap- 
prox. 600 bp of the 3' -non-coding region exhibited 
very poor growth [4]. As a clone containing only 
135 bp of the 3'-non-coding region did apparently 
not show this growth inhibitory effect [4], one can 
assume that the 3'-non-coding part of the cDNA 
is responsible for the inhibition, but that a suffi- 
cient length of the 3'-non-coding region is 
necessary to achieve it. 
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